Çмú´ëȸ VOD

´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦59Â÷ Çмú´ëȸ

Korean Society of Coloproctology 59th Annual Meeting
ÀÏ ½Ã: 2026³â 3¿ù 27ÀÏ~ 3¿ù 29ÀÏ, Àå ¼Ò: ·Ôµ¥È£Åںλê

2026³â 3¿ù 27ÀÏ(±Ý)

[Abstract 1] IBD/Benign

09:30-09:37 Impact of Intraoperative Controlled Urinary Leakage on Postoperative Adhesive Small Bowel Obstruction in Locally Advanced Colorectal Cancer Á¶ÀºÇý °í·Á´ëÇб³ ¾È¾Ïº´¿ø
09:37-09:45 Clinical Characteristics and Prognosis of Pediatric-Onset Inflammatory Bowel Disease: A Nationwide Population-Based Study Using a 17-Year Age Cut off ¹ÚÁØ¿µ ÇѾçÀǴ뺴¿ø
09:45-09:52 Procedure-Specific Learning Curves and Safety Adaptation in DaVinci¢ç SP-Robotic Colorectal Surgery Á¶¼ººÀ ¿¬¼¼ÀÇ´ë
09:52-10:00 Age-Stratified Probability of Newly Diagnosed Crohn’s Disease in Patients Undergoing Surgery for Perianal Abscess or Fistula ±èÁö¹Î ¼­¿ï¼Ûµµº´¿ø
10:00-10:07 Emergent Hartmann’s Procedure for Colon Perforation: Over a 10-Year Review of Single Center Á¤Àçö ÀÎÇÏÀÇ´ë
10:07-10:15 Preoperative Biologics Delay Disease Progression in Intestinal Behcet's Disease: A Retrospective Analysis ½Åµ¿Çö ¿¬¼¼ÀÇ´ë
10:15-10:22 Risk Factors for Parastomal Hernia after Stoma Formation: The Protective Role of Stoma Placement within the Rectus Muscle ¿ì»ó¾Æ °Ç¾ç´ëÇб³º´¿ø
10:22-10:30 Short-Term Outcomes of Minimally Invasive Extended Totally Extraperitoneal Repair (eTEP) for Ventral Hernias: A Single-Surgeon Experience ±èÈ£½Â ÀÌÈ­ÀÇ´ë

[Abstract 2] AI & Other Research

09:30-09:40 A Trajectory-Based Auto-Labeling Pipeline: A Novel Deep Learning Strategy for Identifying the Total Mesorectal Excision Plane ÇÏÇå±Õ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø
09:40-09:50 Deep Learning-Based Automated Detection and Classification of Stoma Complications in Clinical Photographs Á¤Áø¹Î ¾ÆÁÖÀÇ´ë
09:50-10:00 Machine Learning Assisted Screening Method for Detection of Colorectal Cancer Risk Using Peripheral Blood Immune Cells ±è´Ù¿î ¼­¿ï¼Ûµµº´¿ø
10:00-10:10 Life Cycle Carbon Footprint of Laparoscopic and Robotic Low Anterior Resection in the Operating Room ÃÖ¹ÌÁ¤ ºÐ´ç¼­¿ï´ëÇб³º´¿ø
10:10-10:20 Machine Learning-Based Risk Scoring Using Clinical and Surgical Variables for Severe Complications After Rectal Cancer Surgery ¼Û½ÂÈ£ °æºÏ´ëÇб³º´¿ø
10:20-10:30 User Perceptions of an Artificial Intelligence-Based Computer-Aided Detection System in Colonoscopy: A Single-Center Exploratory Survey Study °í¼±¿µ ±¹¸³¾Ï¼¾ÅÍ

[Abstract 3] Neoplasia I

09:30-09:40 Upfront Surgery versus Preoperative Chemoradiation in Locally Advanced Mid Rectal Cancer: Reevaluating the Role of PCRT °­Àçö ¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø
09:40-09:50 Clinical Outcomes According to Treatment Modality and Lymph Node Metastasis Risk in Intermediate-Sized (10-20 mm) Rectal Neuroendocrine Tumors : A Multicenter Retrospective Study ¹Ú¼º½Ç ÇѾç´ë¼­¿ïº´¿ø
09:50-10:00 Is Tumor Size an Independent Prognostic Factor in Colon Cancer? A Propensity Score- Matched Study ¾çÇö±Ô ±¹¸³¾Ï¼¾ÅÍ
10:00-10:10 CEA to Skeletal Muscle Index Ratio as a Novel Prognostic Marker in Patients with Colorectal Cancer À̵¿Èñ ±¹¹æºÎ, Àǹ«»ç·ÉºÎ
10:10-10:20 Incidence, Risk Factors, and Clinical Significance of Portomesenteric Vein Thrombosis (PMVT) Detected After Colorectal Cancer Surgery: A Retrospective Analysis ±èâȯ °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø
10:20-10:30 Rethinking Surgical Strategy for Margin-Positive Only T1 Colorectal Cancer : Multicenter Retrospective Cohort Study of the Catholic Colorectal Group ¹ÚÁøÇü °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø

[State-of-the-Art] Updates of Translational Research

10:40-11:00 Organoids in the Management of Refractory Intestinal Ulcers À¯Á¾¸¸ Â÷ÀǰúÇдëÇб³, ¿À°¡³ëÀ̵å»çÀ̾ð½º
11:00-11:20 Microbiome-Based Approaches for Treating Colorectal Diseases and Cancer ¹ÚÇѼö GIST, Áö³ð¾ØÄÄÆÛ´Ï
11:20-11:40 Toward Next-Generation Cancer Vaccines in Colorectal Cancer ½ÅÀÇö KAIST, Ƽ¼¿·ÎÁö
11:40-12:00 Decoding the Tumor Microenvironment of Colorectal Cancer Using Spatial Transcriptomics ¹Ú¿õ¾ç ¼º±Õ°ü´ëÇб³, Áö´Ï³Ê½º

[Áø·á±Ç°í¾ÈÀ§¿øÈ¸] Clinical Issues in Anal Cancer Management for Guideline Development

10:40-10:50 Guideline Development Process Brief Report À¯È¿¼± °í·ÁÀÇ´ë
10:50-11:05 Screening for Anal Cancer in High-risk Populations ±ÇÀ±Çý À»ÁöÀÇ´ë
11:05-11:20 Assessment of Complete Response after CCRT ¹®¼º°æ °æÈñÀÇ´ë ¿µ»óÀÇÇаú
11:20-11:35 Reduced-dose Radiotherapy in Early-stage Anal Cancer ±èÅÂÇü ¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú
11:35-11:50 Alternative Chemotherapy Regimens versus Mitomycin/5-FU based CRT Áö¿õ¹è °í·ÁÀÇ´ë
11:50-12:05 Role of Local Excision in Stage 1 Anal Squamous Cell Carcinoma ±è¹Î¼º ÇѸ²ÀÇ´ë

[Neoplasia] Precision Medicine Meets Surgical Oncology in CRC

10:40-11:00 Neoadjuvant Immunotherapy for MSI-H and MSS Rectal Cancer: Surgical Implications Á¶¿ë¹ü ¼º±Õ°üÀÇ´ë
11:00-11:20 ctDNA-Guided Adjuvant Therapy: When to Escalate or De-escalate Â÷¿ëÁØ ¾ÆÀÌ¿¥ºñµð¿¢½º
11:20-11:40 Molecular Profiling-Based Treatment Strategies for Metastatic CRC ÇÏ±â¿ø ÀüºÏÀÇ´ë
11:40-12:00 Gut Microbiome and Treatment Response in CRC Á¤°æ¿í ¼º±Õ°üÀÇ´ë

Luncheon Symposium 1 [Livsmed]

12:10-12:40 Colorectal Surgery Using the ArtiSeal: A New Standard for Hemostasis and Precision ¹è¼º¿í °è¸íÀÇ´ë

Luncheon Symposium 2 [Daewoong]

12:10-12:40 Á÷Àå¾Ï ¼ö¼ú ÈÄ ¹èº¯ Àå¾Ö °ü¸®¿Í º¯½Ç±Ý Ä¡·áÀÇ »õ·Î¿î ¿É¼Ç: Ramosetron (À̸®ÄÝÁ¤¢ç) À¯½Â¹ü ¼­¿ïÀÇ´ë

Luncheon Seminar 1 [Medtronic]

12:10-12:40 Fast and Safe Surgery with LigaSure¢â ±èÂù¿í ¿ï»êÀÇ´ë

[Chemotherapy] Optimizing TNT Strategy in LARC: Key Debates and Protocol Sharing

13:20-13:40 Why We Choose RT Followed by Consolidation Chemotherapy ±èÇýÁø °æºÏÀÇ´ë
13:40-14:00 Why We Choose Induction Chemotherapy with Selective RT Strategy ÀÌÀ±¼® °¡Å縯ÀÇ´ë
14:00-14:20 Does TNT Really Improve Outcomes? Gap of Evidence and Real Clinical Practice ±èâ¿ì ¾ÆÁÖÀÇ´ë
14:20-14:40 Is Watch-and-Wait Feasible in Korea? Initial Experience and Cultural Barriers ¹ÚÀ±¿µ °æÈñÀÇ´ë

[Benign Colorectal Disease] Multidisciplinary Approach to Emergency Surgery for Benign Colorectal Disease

13:20-13:35 Let the Surgeon Sleep, Keep the Patient Safe: Evidence-Based Timing for Semi-Urgent Colorectal Surgery ÀÌ´ë¼· ºÎ»êÀÇ´ë ÀÀ±ÞÀÇÇаú
13:35-13:50 Drain Today, Operate Right ³²ÀÎÃâ Á¦ÁÖÀÇ´ë ¿µ»óÀÇÇаú
13:50-14:05 Resuscitation Strategy in Postoperative Septic Shock ÀÌ°æ¿ø À»ÁöÀÇ´ë ÁßȯÀÚÀÇÇаú
14:05-14:20 Surgeon-Anesthesiologist Communication Checklist for Colorectal Emergencies ±èÈñ¿µ ºÎ»êÀÇ´ë ¸¶Ãë°ú
14:20-14:50 Panel Discussion ±èÇÑ±æ °æ»óÀÇ´ë
14:20-14:50 Panel Discussion ¿Àâ±Ô ¼º±Õ°üÀÇ´ë

[KQIPS-CRS Workshop] Korean Quality Improvement Platform in Colon and Rectal Surgery

13:20-13:35 KQIPS-CRS: Building a National Prospective Quality Improvement Platform ¾öÁØ¿ø °í·ÁÀÇ´ë
13:35-13:50 Practical Considerations: IRB Approval and Informed Consent À±¼ø¼® °í·ÁÀÇ´ë
13:50-14:05 Prospective eCRF Platform and Data Management ±Ç¿Àö MDB Inc.
14:05-14:20 From Contract to Management: Budget Execution ¾ÈÄ¡¹ü °í·ÁÀÇ´ë
14:20-14:35 Development of Guidelines & Clinical Pathways ºÀÁØ¿ì °í·ÁÀÇ´ë
14:35-14:50 Unified Data, Unified Strength: The Strategic Future of KSCP ¹ÚÁö¿ø ¼­¿ïÀÇ´ë

[Debate_Neoplasia] Organ Preservation for Rectal Cancer

15:10-15:25 Organ Preservation for cT2N0 Rectal Cancer. Two Strategies in Focus.
Local Excision Followed by Adjuvant Chemotherapy or Radiotherapy
ÇãÁ¤¿í ¼º±Õ°üÀÇ´ë
15:25-15:40 Organ Preservation for cT2N0 Rectal Cancer. Two Strategies in Focus.
Neoadjuvant Treatment Followed by Watch-and-Wait or Local Excision
À̵¿¿î ±¹¸³¾Ï¼¾ÅÍ
15:40-15:55 Managing Positive Margins after Local Excision in Early Rectal Cancer
Re-local Excision or Adjuvant Treatment Aiming Organ Preservation
¹èÁ¤ÈÆ °¡Å縯ÀÇ´ë
15:55-16:10 Managing Positive Margins after Local Excision in Early Rectal Cancer
Why TME Remains the Oncologically Safe Choice
±è¿µÀÏ ¿ï»êÀÇ´ë

[Surgical Assistant] Surgeon-Surgical Assistants Collaboration to Ensure Safe and High-Quality Surgery

15:10-15:25 Proactive Strategies by Surgical Assistant in Enhancing Intraoperative Flow À̹ÌÁö ºÎ»ê¹éº´¿ø
15:25-15:40 Enhancing the Role of the Surgical Assistant in Colorectal Surgery ¼º³«¼Û °Ç¾çÀÇ´ë
15:40-15:55 Advancing Surgical Skill and Professional Development Strategies for the Surgical Assistant ÃÖÀ¸¶ä ¼­¿ï¾Æ»êº´¿ø
15:55-16:10 What is the Critical Competency of a Surgical Assistant to Contribute to Emergency Surgery or Terrible Situations? ±èÇÑ±æ °æ»óÀÇ´ë
16:10-16:40 Panel Discussion ±ÇÇý¿¬ ¿¬¼¼¿øÁÖÀÇ´ë

[AI Workshop] ´ëÀåÇ×¹®¿Ü°úÀǸ¦ À§ÇÑ AI ¸®ÅÍ·¯½Ã

15:10-15:30 ¿¬±¸ ¼³°è ¹× ÀÚ·á Ž»öÀÇ ³ëÇÏ¿ì ¾Ë±â ÃÖ¿µÁØ ·çºñÄÜ Å×Å©
15:30-15:50 ¿¬±¸ÀÚ·á Á¤¸®, Åë°è ºÐ¼® ÀÚµ¿È­ ±â¹ý ¹è¿ì±â ÃÖ¿µÁØ ·çºñÄÜ Å×Å©
15:50-16:10 ³í¹® ÃÊ¾È ÀÛ¼º ¹× Åõ°íÀü ÇǾºä ½Ã¹Ä·¹ÀÌ¼Ç È°¿ëÇϱâ ÃÖ¿µÁØ ·çºñÄÜ Å×Å©
16:10-16:30 ¿¬±¸ ±×·¡ÇÈ ¹× ¹ßÇ¥ PPT »ý¼º ¹æ¹ý ¸¶½ºÅÍÇϱâ ÃÖ¿µÁØ ·çºñÄÜ Å×Å©

[Abstract 4] Neoplasia II

17:00-17:10 Indirect Validation of a Total Neoadjuvant Therapy Protocol in Locally Advanced Rectal Cancer Using an AI-Based Multidisciplinary Simulation °­½Â¿¬ ¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø
17:10-17:20 Diagnostic Performance of Sigmoidoscopy and MRI in Patients Suspected of Good Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer ÀÌÈ£¿µ ºÐ´ç¼­¿ï´ëÇб³º´¿ø
17:20-17:30 The Paradoxical Features of Tumor Size in T4 Colon Cancer: A Retrospective Cohort Study ÀåÁø±â ¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø
17:30-17:40 Patient Preferences for Robotic Surgery in Low-Risk Thyroid Cancer Versus High-Risk Colorectal Cancer ±è¿µÀÏ ¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø
17:40-17:50 Risk Factors for Lateral Pelvic Node Recurrence After Total Mesorectal Excision in Rectal Cancer Patients With Responsive Lateral Pelvic Nodes Following Chemoradiotherapy °­°æ¹Î ºÐ´ç¼­¿ï´ëÇб³º´¿ø
17:50-18:00 Learning Curve of Da Vinci Single-Port Robotic Colorectal Cancer Surgery: Impact of Prior Robotic Experience À̼ö¿µ È­¼øÀü³²´ëÇб³º´¿ø

[Abstract 5] Translational Research

17:00-17:10 Circulating Microbial Cell-Free DNA with Unmethylated CpG Motifs as a Novel Biomarker for T-Cell Exhaustion and Immunotherapy Resistance in Colorectal Cancer °­µ¿Çö ¼øÃµÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø
17:10-17:20 Evaluation of the Cancer-Inhibitory Effect of Attenuated Salmonella in Colorectal Cancer Peritoneal Metastasis: A Syngeneic Mouse Model ¹ÚÇü¹Î È­¼øÀü³²´ëÇб³º´¿ø
17:20-17:30 Single-Cell RNA-Sequencing and Spatial Transcriptomics Integration Identifies a Neuro-Mesenchymal Niche Driving Perineural Invasion in Colorectal Cancer Ç¥´ëÈñ °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø
17:30-17:40 Integrated Transcriptomic and Genomic Analysis of the Tumor Immune Microenvironment and Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer ±èÈ¿ÁØ ¼­¿ï´ëÇб³º´¿ø
17:40-17:50 Myogenic Maturation of Adipose-Derived MSC Spheroids Enhances Muscle Reconstruction in a Mouse Model of Anal Sphincter Injury ¾çÀÎÁØ Ãæ³²´ëÇб³º´¿ø
17:50-18:00 Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Enhances Growth Inhibition in Solid Tumor Cell Lines ±èÁø¼ö Ãæ³²´ëÇб³º´¿ø

[Abstract 6] Neoplasia III

17:00-17:10 Local Excision with Chemoradiotherapy as an Alternative to Curative Resection for Stage I Rectal Cancer ¹éÁøÈñ °Ç±¹ÀÇ´ë  
17:10-17:20 Lymphopenia and CRP Elevation on the Postoperative Day 2 Are Independent Risk Factors for Detection of Major and Minor Complications in Elective Colorectal Cancer Surgery ¹Ú¹Î¼­ Á¶¼±ÀÇ´ë
17:20-17:30 Optimal Surgical Timing of Resectable Colorectal Liver Metastases ±èµ¿ÇÏ Ãæ³²´ëÇб³º´¿ø
17:30-17:40 Risk of Metabolic Disease After Right- vs Left-Sided Colectomy for Colon Cancer: A Nationwide Cohort Study ¿À¼ö¿µ ¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø
17:40-17:50 Comparison of Treatment Outcomes Before and After Implementation of Integrated Nursing Care Services in Colorectal Cancer Surgery under ERAS ¹Ú¼öÁö °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø
17:50-18:00 Serial ctDNA Monitoring in Stage IV Colorectal Cancer: Final Results ±èÇö°æ °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø